VitaMed is a specialty pharmaceutical company that has developed a patent pending technology and business methodology to market both over the counter OTC and prescription versions of nutritional supplements, drugs, medical foods and other medical products directly to consumers with the recommendation of their physician. VitaMed s business model creates unique value propositions for patients, physician/providers and insurance payors by eliminating much of the inefficiencies associated with the traditional sales, marketing and distribution models. VitaMed offers superior quality products for a lower overall cost to patients and payors while increasing efficiencies for physicians. VitaMed s technology allows it to collect and analyze data from various sources to improve patient compliance and education, facilitate product development and provide immediate feedback on effectiveness of therapies. The result is increased efficiency and communication between the patient, physician/provider and insurance payor, ultimately creating improved outcomes for all. This combination of efficient distribution and technology provides measurable customer benefits differentiates VitaMed from existing competitors in the market.
Quote | TherapeuticsMD Inc. (NASDAQ:TXMD)
Last: | $1.6204 |
---|---|
Change Percent: | -2.39% |
Open: | $1.65 |
Close: | $1.66 |
High: | $1.745 |
Low: | $1.6204 |
Volume: | 4,087 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | TherapeuticsMD Inc. (NASDAQ:TXMD)
2024-06-28 11:52:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips TherapeuticsMD (NASDAQ: TXMD ) just reported results for the fourth quarter of 2023. TherapeuticsMD reported earnings per share of -14 cents. The company reported reve...
2024-05-30 16:55:01 ET In its annual 2024 Russell index reconstitution, about 213 companies will be added and 198 deleted from the Russell Microcap Index. Read the full article on Seeking Alpha For further details see: Nektar, Verastem among healthcare additions in Russe...
Message Board Posts | TherapeuticsMD Inc. (NASDAQ:TXMD)
Subject | By | Source | When |
---|---|---|---|
look to put money back in stocks around Feburary.. | jablome | investorshub | 12/29/2022 5:14:48 PM |
SaltyMutt: TY for reminding me of TXMD. I haven't thought about it in a while. | SaltyMutt | investorshangout | 12/05/2022 9:10:03 PM |
znewcar1: $TXMD HOD5.84 28% v2,15m $5.695 f9,467,104 | znewcar1 | investorshangout | 12/05/2022 6:41:07 PM |
November 30? | JCB5 | investorshub | 12/05/2022 2:07:06 PM |
should see bankruptcy or buyout soon on nov. | magacrew2020 | investorshub | 11/25/2022 5:45:40 PM |
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...